Is FOXO4-DRI safe?

Limited Evidence

Side effects, risks, and safety considerations based on available research.

Research status

FOXO4-DRI has very limited human safety data. Most information comes from animal studies, in vitro research, or anecdotal reports. This means the true risk profile in humans is largely unknown.

Known concerns & side effects

  • no human clinical trials have been completed — only one mouse study published
  • mouse doses were high (5mg/kg IP 3× per week) — human-equivalent dosing and route entirely unstudied
  • senescent cells are not entirely harmful — some serve wound healing and embryonic development roles; indiscriminate elimination could have unintended consequences
  • FOXO4-DRI sold online as a "research peptide" is almost certainly not pharmaceutical-grade
  • long-term consequences of senescent cell depletion in humans are unknown

Use caution with

active wound healing — senescent cells contribute to wound repair; senolytics could impair recoveryanyone not under expert medical supervision — risk-benefit in humans entirely unknown

See all 1 studies on the full FOXO4-DRI profile.

Frequently asked questions

How significant were the mouse results?

The 2017 Cell paper by Baar et al. was genuinely striking — treated mice regained dense fur, improved grip strength, and markedly improved exercise endurance within weeks. Mice treated after chemotherapy recovered lost physical function. The results generated enormous media coverage in longevity circles. However, mouse aging models often do not translate to humans, and the doses were very high.

Is FOXO4-DRI the same as navitoclax or dasatinib+quercetin?

No — these are different senolytic approaches. Dasatinib+quercetin and navitoclax work through Bcl-2 family inhibition. FOXO4-DRI specifically targets the FOXO4-p53 interaction. They are being studied in parallel. FOXO4-DRI is the only peptide-based senolytic with published in vivo data.

Full FOXO4-DRI Profile

Evidence, timeline, products & more

Take the Peptide Quiz

Get personalized recommendations

Last updated: 2026-06-10

Medical Disclaimer

The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.